Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: IR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on IR, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 619 IR shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 619 shares
    Change vs previous 13F -325 shares

    <0.01% of the 13F portfolio, value $50,752.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 944 shares
    Change vs previous 13F +442 shares

    <0.01% of the 13F portfolio, value $75,633.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 502 shares
    Change vs previous 13F +16 shares

    <0.01% of the 13F portfolio, value $39,771.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 486 shares
    Change vs previous 13F +173 shares

    <0.01% of the 13F portfolio, value $40,156.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 313 shares
    Change vs previous 13F +38 shares

    <0.01% of the 13F portfolio, value $26,037.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 275 shares
    Change vs previous 13F -38 shares

    <0.01% of the 13F portfolio, value $22,010.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 313 shares
    Change vs previous 13F -54 shares

    <0.01% of the 13F portfolio, value $28,316.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 367 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $36,027.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).